| Status | Study |
| Not yet recruiting |
Study Name: Salivary Free Cortisol Response to Cosyntropin Stimulation Test in Mitotane Treated Patients Condition: Adrenal Insufficiency Adrenal Cancer Date: 2017-03-14 Interventions: Diagnostic Test: Cosyntropin stimulation test At 0800h to 0900h, a 25 mm plastic intravenous line will b |
| Recruiting |
Study Name: Towards an Easy-to-use Adrenal Cancer/Tumor Identity Card Condition: Adrenal Gland Neoplasms Date: 2016-01-14 Interventions: Biological: omics identity card |
| Recruiting |
Study Name: Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma Condition: Adrenocortical Carcinoma Adrenal Cancer Date: 2013-07-10 Interventions: Drug: ATR-101 |
| Terminated |
Study Name: Possible New Therapy for Advanced Cancer Condition: Adrenocortical Carcinoma Date: 2012-09-11 Interventions: Drug: IL-13-PE IL-13-PE intravenous infusion Other N |
| Recruiting |
Study Name: Evaluation of Molecular Markers in Adrenal Tumors Condition: Adrenal Gland Neoplasms Date: 2011-05-04 |
| Completed |
Study Name: Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer Condition: Non-Small-Cell Lung Carcinoma Liver Cancer Date: 2010-08-18 Interventions: Radiation: stereotactic body radiation therapy For lung, liver, axial skeleton, and adrenal tumors a dos |
| Terminated |
Study Name: A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers Condition: Breast Cancer Lung Cancer Renal Cancer Date: 2010-03-12 Interventions: Drug: FPAC Each subject will be administered 7 mCi of FPAC,over 10-20 seconds, followed by saline flush. |
| Recruiting |
Study Name: Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms Condition: Endocrine Neoplasms Thyroid Neoplasms Parathyroid Neoplasm Date: 2009-10-30 |
| Recruiting |
Study Name: Evaluation of Side Effects of Mitotane Condition: Adrenocortical Carcinoma Date: 2007-12-04 |
| Completed |
Study Name: Sunitinib in Refractory Adrenocortical Carcinoma Condition: Adrenocortical Carcinoma Date: 2007-03-28 Interventions: Drug: Sunitinib |